When the physician applies cantharidin to molluscum-contagiosum lesions (ie, wart-like lesions), would this qualify as chemosurgical destruction as intended by codes 17110 - 17111 ? ...
Subscribe or sign in to view the full article.
Article Overview
This coding Q&A addresses CPT guidance for reporting destruction of benign lesions when chemical treatment is used for molluscum contagiosum. It is relevant to professional coders, dermatology practices, and billing staff who need to understand the scope of CPT destruction services, lesion-count-based code selection, and how the codebook characterizes destruction methods. The article also references the CPT codebook’s general concept of destruction and its inclusion of multiple treatment modalities and lesion types.
Why This Topic Matters
Correctly categorizing lesion destruction services affects CPT reporting consistency for dermatology and related procedures. The article helps readers recognize when a chemical approach is discussed in the same context as other destruction methods and why lesion count remains a key part of the CPT framework.
What You Will Learn
- How CPT describes destruction of lesions in general terms
- How lesion count relates to the two benign-lesion destruction codes discussed
- Which general treatment modalities are referenced in the CPT codebook context
- How molluscum contagiosum is treated in the context of lesion destruction reporting
Who Should Read This
- Professional coders
- Dermatology billing staff
- Physician office staff
- Compliance and audit personnel
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.

Quick, Current, Complete - www.findacode.com